-
1
المؤلفون: de la Court, JR, Janssen, JJWM, de Jonge, NA, Kuijvenhoven, MA, Bomers, MK, Schade, RP, Sigaloff, KCE
المساهمون: Medical Microbiology and Infection Control, CCA - Treatment and quality of life, CCA - Imaging and biomarkers, Hematology, Internal medicine, Clinical pharmacology and pharmacy, AII - Infectious diseases, ACS - Diabetes & metabolism, APH - Quality of Care
المصدر: de la Court, JR, Janssen, JJWM, de Jonge, NA, Kuijvenhoven, MA, Bomers, MK, Schade, RP & Sigaloff, KCE 2018, ' Empirische antibiotische therapie voor koorts bij neutropenie in Nederland ', Nederlands tijdschrift voor medische microbiologie, vol. 26, no. 3 .
Nederlands tijdschrift voor medische microbiologie, 26(3). Elsevier BVURL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fc92f1b13c353d09eed883c1dd946bdb
https://research.vumc.nl/en/publications/75123bef-22da-4fd9-826b-4d57705590f3 -
2دورية أكاديمية
المؤلفون: Gramberg MCTT; Amsterdam UMC Location Vrije Universiteit Amsterdam, Infectious Diseases, De Boelelaan 1117, Amsterdam, The Netherlands. m.gramberg@amsterdamumc.nl.; Amsterdam Movement Sciences, Rehabilitation and Development, Amsterdam, The Netherlands. m.gramberg@amsterdamumc.nl.; Amsterdam Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands. m.gramberg@amsterdamumc.nl.; Amsterdam UMC Center for Diabetic Foot Complications (ACDC), Amsterdam, The Netherlands. m.gramberg@amsterdamumc.nl., Mahadew SKN; Amsterdam UMC Location Vrije Universiteit Amsterdam, Infectious Diseases, De Boelelaan 1117, Amsterdam, The Netherlands., Lissenberg-Witte BI; Amsterdam UMC Location Vrije Universiteit Amsterdam, Epidemiology and Data Science, De Boelelaan 1117, Amsterdam, The Netherlands., Bleijenberg MP; Amsterdam UMC Location Vrije Universiteit Amsterdam, Infectious Diseases, De Boelelaan 1117, Amsterdam, The Netherlands., de la Court JR; Amsterdam UMC Location Vrije Universiteit Amsterdam, Infectious Diseases, De Boelelaan 1117, Amsterdam, The Netherlands.; Amsterdam Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands., van Hattem JM; Amsterdam UMC Location University of Amsterdam Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, The Netherlands., Sabelis LWE; Amsterdam Movement Sciences, Rehabilitation and Development, Amsterdam, The Netherlands.; Amsterdam UMC Location Vrije Universiteit Amsterdam, Rehabilitation Medicine, De Boelelaan 1117, Amsterdam, The Netherlands.; Amsterdam UMC Center for Diabetic Foot Complications (ACDC), Amsterdam, The Netherlands., Lagrand RS; Amsterdam Movement Sciences, Rehabilitation and Development, Amsterdam, The Netherlands.; Amsterdam UMC Location Vrije Universiteit Amsterdam, Rehabilitation Medicine, De Boelelaan 1117, Amsterdam, The Netherlands.; Amsterdam UMC Center for Diabetic Foot Complications (ACDC), Amsterdam, The Netherlands., de Groot V; Amsterdam Movement Sciences, Rehabilitation and Development, Amsterdam, The Netherlands.; Amsterdam UMC Location Vrije Universiteit Amsterdam, Rehabilitation Medicine, De Boelelaan 1117, Amsterdam, The Netherlands.; Amsterdam UMC Center for Diabetic Foot Complications (ACDC), Amsterdam, The Netherlands., Heijer MD; Amsterdam UMC Location Vrije Universiteit Amsterdam, Endocrinology, De Boelelaan 1117, Amsterdam, The Netherlands., Peters EJG; Amsterdam UMC Location Vrije Universiteit Amsterdam, Infectious Diseases, De Boelelaan 1117, Amsterdam, The Netherlands.; Amsterdam Movement Sciences, Rehabilitation and Development, Amsterdam, The Netherlands.; Amsterdam Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.; Amsterdam UMC Center for Diabetic Foot Complications (ACDC), Amsterdam, The Netherlands.
المصدر: Infection [Infection] 2023 Apr; Vol. 51 (2), pp. 347-354. Date of Electronic Publication: 2022 Jul 22.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Heidelberg Country of Publication: Germany NLM ID: 0365307 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-0973 (Electronic) Linking ISSN: 03008126 NLM ISO Abbreviation: Infection Subsets: MEDLINE
مواضيع طبية MeSH: Diabetic Foot*/complications , Diabetic Foot*/microbiology , Diabetic Foot*/pathology , Staphylococcal Infections*/microbiology , Communicable Diseases*/drug therapy , Diabetes Mellitus*, Humans ; Retrospective Studies ; Ulcer/drug therapy ; Bacteria ; Anti-Bacterial Agents/therapeutic use
-
3دورية أكاديمية
المؤلفون: de la Court JR; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam, The Netherlands. j.delacourt@amsterdamumc.nl.; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam, The Netherlands. j.delacourt@amsterdamumc.nl., Heijmans J; Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Huynh J; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Sieswerda E; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., de Jonge NA; Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., van Dijk K; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Sigaloff KCE; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Schade RP; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.
المصدر: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2022 Dec 18; Vol. 11 (1), pp. 160. Date of Electronic Publication: 2022 Dec 18.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101585411 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-2994 (Electronic) Linking ISSN: 20472994 NLM ISO Abbreviation: Antimicrob Resist Infect Control Subsets: MEDLINE
مواضيع طبية MeSH: Bacteremia*/epidemiology , Anti-Infective Agents*/therapeutic use , Neutropenia* , Sepsis*/epidemiology, Adult ; Humans ; Retrospective Studies ; Carbapenems/therapeutic use ; Carbapenems/pharmacology ; Pseudomonas aeruginosa
-
4دورية أكاديمية
المؤلفون: de la Court JR; Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Microbiology and Infection Prevention, University of Amsterdam, Amsterdam, The Netherlands., Bruns AHW; Department of Infectious Diseases, University Medical Centre Utrecht, University of Utrecht, Utrecht, The Netherlands., Roukens AHE; Department of Infectious Diseases, Leiden University Centre of Infectious Diseases, Leiden University Medical Centre, Leiden University, Leiden, The Netherlands., Baas IO; Department of Medical Oncology, University Medical Centre Utrecht, University of Utrecht, Utrecht, The Netherlands., van Steeg K; Department of Clinical Pharmacology, ZGT Hospital, University of Groningen, Almelo and Hengelo, The Netherlands., Toren-Wielema ML; Department of Clinical Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Tersmette M; Department of Medical Microbiology and Immunology, Sint Antonius Hospital, Nieuwegein and Utrecht, The Netherlands., Blijlevens NMA; Department of Haematology, Radboud University Medical Centre, Radboud University, Nijmegen, The Netherlands., Huis In 't Veld RAG; Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Wolfs TFW; Division of Paediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Tissing WJE; Department of Pediatric Oncology and Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pediatric Oncology and Hematology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kyuchukova Y; Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Heijmans J; Department of Haematology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. j.heijmans@amsterdamumc.nl.
المصدر: Infectious diseases and therapy [Infect Dis Ther] 2022 Dec; Vol. 11 (6), pp. 2063-2098. Date of Electronic Publication: 2022 Oct 14.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
-
5دورية أكاديمية
المؤلفون: de la Court JR; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. j.delacourt@amsterdamumc.nl.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. j.delacourt@amsterdamumc.nl., Woudt SHS; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Schoffelen AF; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Heijmans J; Department of Haematology, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Jonge NA; Department of Haematology, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van der Bruggen T; Department of Medical Microbiology, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands., Bomers MK; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Lambregts MMC; Department of Infectious Diseases, Leiden University Medical Centre, Leiden University, Leiden, The Netherlands., Schade RP; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Sigaloff KCE; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
مؤلفون مشاركون: ISIS-AR study group
المصدر: Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2022 Nov 28; Vol. 21 (1), pp. 54. Date of Electronic Publication: 2022 Nov 28.
نوع المنشور: Multicenter Study; Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101152152 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-0711 (Electronic) Linking ISSN: 14760711 NLM ISO Abbreviation: Ann Clin Microbiol Antimicrob Subsets: MEDLINE
مواضيع طبية MeSH: Bacteremia*/drug therapy , Hematologic Neoplasms*/complications , Hematologic Neoplasms*/drug therapy, Humans ; Retrospective Studies ; Prospective Studies ; Carbapenems ; Ceftazidime
-
6دورية أكاديمية
المؤلفون: van den Broek AK; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de la Court JR; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. j.delacourt@amsterdamumc.nl.; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. j.delacourt@amsterdamumc.nl., Groot T; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van Hest RM; Division of Clinical Pharmacology, Department of Hospital Pharmacy, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Visser CE; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Sigaloff KCE; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Schade RP; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Prins JM; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
المصدر: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2022 Aug 29; Vol. 11 (1), pp. 110. Date of Electronic Publication: 2022 Aug 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101585411 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-2994 (Electronic) Linking ISSN: 20472994 NLM ISO Abbreviation: Antimicrob Resist Infect Control Subsets: MEDLINE
مواضيع طبية MeSH: Aftercare* , Antimicrobial Stewardship*, Adult ; Anti-Bacterial Agents/therapeutic use ; Guideline Adherence ; Humans ; Patient Discharge
-
7
المؤلفون: Douiyeb S; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands. s.douiyeb@amsterdamumc.nl., de la Court JR; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Tuinte B; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands., Sombogaard F; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands., Schade RP; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Kuijvenhoven M; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands., Minderhoud T; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands., Sigaloff KCE; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands.
المصدر: International journal of clinical pharmacy [Int J Clin Pharm] 2022 Jun; Vol. 44 (3), pp. 834.
نوع المنشور: Published Erratum
بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: PubMed not MEDLINE; MEDLINE
-
8دورية أكاديمية
المؤلفون: Douiyeb S; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands. s.douiyeb@amsterdamumc.nl., de la Court JR; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Tuinte B; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands., Sombogaard F; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands., Schade RP; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Kuijvenhoven M; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands., Minderhoud T; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands., Sigaloff KCE; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands.
المصدر: International journal of clinical pharmacy [Int J Clin Pharm] 2022 Apr; Vol. 44 (2), pp. 557-563. Date of Electronic Publication: 2022 Feb 14.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE
مواضيع طبية MeSH: Anti-Infective Agents*/adverse effects , Anti-Infective Agents*/therapeutic use , Patient Readmission*, Ambulatory Care/methods ; Aminoglycosides ; Anti-Bacterial Agents/adverse effects ; Humans ; Infusions, Parenteral ; Outpatients ; Retrospective Studies ; Risk Factors ; Vancomycin/adverse effects
-
9دورية أكاديمية
المؤلفون: Coenen S; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Univ of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., de la Court JR; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Univ of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., Buis DTP; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands., Meijboom LJ; Department of Radiology and Nuclear Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands., Schade RP; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Univ of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., Visser CE; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Univ of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., van Hest R; Department of Clinical Pharmacy and Pharmacology, Amsterdam UMC, Univ of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., Kuijvenhoven M; Department of Clinical Pharmacy and Pharmacology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands., Prins JM; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands., Nijman SFM; Department of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands., Sieswerda E; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Univ of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., Sigaloff KCE; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. k.sigaloff@amsterdamumc.nl.
المصدر: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2021 Oct 30; Vol. 10 (1), pp. 155. Date of Electronic Publication: 2021 Oct 30.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101585411 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-2994 (Electronic) Linking ISSN: 20472994 NLM ISO Abbreviation: Antimicrob Resist Infect Control Subsets: MEDLINE
مواضيع طبية MeSH: Bacterial Infections/*epidemiology , COVID-19/*diagnosis , Coinfection/*epidemiology , Community-Acquired Infections/*epidemiology , Hospitalization/*statistics & numerical data , Pneumonia/*epidemiology, Adult ; Anti-Bacterial Agents/therapeutic use ; Antimicrobial Stewardship ; Bacterial Infections/drug therapy ; Bacterial Infections/microbiology ; COVID-19/complications ; Cohort Studies ; Coinfection/drug therapy ; Community-Acquired Infections/microbiology ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; SARS-CoV-2
-
10دورية أكاديمية
المؤلفون: Bakkum MJ; Department of Internal Medicine, Section Pharmacotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Richir MC; Department of Internal Medicine, Section Pharmacotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Sultan R; Department of Internal Medicine, Section Pharmacotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., de la Court JR; Department of Internal Medicine, Section Pharmacotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Lambooij AC; Dutch Institute For Rational Use of Medicines (IVM), Churchilllaan 11, 3527 GV Utrecht, The Netherlands., van Agtmael MA; Department of Internal Medicine, Section Pharmacotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; https://www.eacpt.eu/., Tichelaar J; Department of Internal Medicine, Section Pharmacotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; https://www.eacpt.eu/.
المصدر: Medical science educator [Med Sci Educ] 2021 Oct 15; Vol. 31 (6), pp. 1739-1745. Date of Electronic Publication: 2021 Oct 15 (Print Publication: 2021).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101625548 Publication Model: eCollection Cited Medium: Internet ISSN: 2156-8650 (Electronic) Linking ISSN: 21568650 NLM ISO Abbreviation: Med Sci Educ Subsets: PubMed not MEDLINE